Found: 23
Select item for more details and to access through your institution.
Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma.
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-019-0840-4
- By:
- Publication type:
- Article
Pooled safety analyses of ALK-TKI inhibitor in ALK-positive NSCLC.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The Efficacy of Cytokine-Induced Killer Cell Infusion as an Adjuvant Therapy for Postoperative Hepatocellular Carcinoma Patients.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2013, v. 20, n. 13, p. 4305, doi. 10.1245/s10434-013-3144-x
- By:
- Publication type:
- Article
Annexin A3 as a Potential Target for Immunotherapy of Liver Cancer Stem-Like Cells.
- Published in:
- Stem Cells, 2015, v. 33, n. 2, p. 354, doi. 10.1002/stem.1850
- By:
- Publication type:
- Article
CIK cell cytotoxicity is a predictive biomarker for CIK cell immunotherapy in postoperative patients with hepatocellular carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 5, p. 825, doi. 10.1007/s00262-020-02486-y
- By:
- Publication type:
- Article
New nomograms to predict overall and cancer‐specific survival of angiosarcoma.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 1, p. 74, doi. 10.1002/cam4.4425
- By:
- Publication type:
- Article
Safety and Tolerability of BRAF Inhibitor and BRAF Inhibitor-Based Combination Therapy in Chinese Patients With Advanced Melanoma: A Real World Study.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.582676
- By:
- Publication type:
- Article
Phase I study of pegylated liposomal doxorubicin and cisplatin in patients with advanced osteosarcoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2022, v. 89, n. 2, p. 209, doi. 10.1007/s00280-021-04371-6
- By:
- Publication type:
- Article
Correction: Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Galectin-3 favours tumour metastasis via the activation of β-catenin signalling in hepatocellular carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma.
- Published in:
- 2014
- By:
- Publication type:
- journal article
HUS1 checkpoint clamp component (HUS1) is a potential tumor suppressor in primary hepatocellular carcinoma.
- Published in:
- Molecular Carcinogenesis, 2019, v. 58, n. 1, p. 76, doi. 10.1002/mc.22908
- By:
- Publication type:
- Article
Dendritic-cell-based immunotherapy evokes potent anti-tumor immune responses in CD105+ human renal cancer stem cells.
- Published in:
- Molecular Carcinogenesis, 2017, v. 56, n. 11, p. 2499, doi. 10.1002/mc.22697
- By:
- Publication type:
- Article
Expression and Prognostic Role of Ubiquitination Factor E4B in Primary Hepatocellular Carcinoma.
- Published in:
- Molecular Carcinogenesis, 2016, v. 55, n. 1, p. 64, doi. 10.1002/mc.22259
- By:
- Publication type:
- Article
Annexin A3 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma.
- Published in:
- Molecular Carcinogenesis, 2015, v. 54, n. 8, p. 598, doi. 10.1002/mc.22126
- By:
- Publication type:
- Article
XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial
- Published in:
- Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-024-01788-2
- By:
- Publication type:
- Article
Retrospective analysis of the efficacy of cytokine‐induced killer cell immunotherapy combined with first‐line chemotherapy in patients with metastatic colorectal cancer.
- Published in:
- Clinical & Translational Immunology, 2020, v. 9, n. 2, p. 1, doi. 10.1002/cti2.1113
- By:
- Publication type:
- Article
A Nomogram for Predicting the Benefit of Adjuvant Cytokine-Induced Killer Cell Immunotherapy in Patients with Hepatocellular Carcinoma.
- Published in:
- Scientific Reports, 2015, p. 9202, doi. 10.1038/srep09202
- By:
- Publication type:
- Article
IL-37 induces anti-tumor immunity by indirectly promoting dendritic cell recruitment and activation in hepatocellular carcinoma.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 6691, doi. 10.2147/CMAR.S200627
- By:
- Publication type:
- Article
Orchestration of immune checkpoints in tumor immune contexture and their prognostic significance in esophageal squamous cell carcinoma.
- Published in:
- Cancer Management & Research, 2018, v. 10, p. 6457, doi. 10.2147/CMAR.S181949
- By:
- Publication type:
- Article
Association between high expression of phosphorylated Akt and mammalian target of rapamycin and improved survival in salivary gland adenoid cystic carcinoma.
- Published in:
- Head & Neck, 2017, v. 39, n. 6, p. 1145, doi. 10.1002/hed.24732
- By:
- Publication type:
- Article
Screening and identification of hub genes in bladder cancer by bioinformatics analysis and KIF11 is a potential prognostic biomarker.
- Published in:
- Oncology Letters, 2021, v. 21, n. 3, p. N.PAG, doi. 10.3892/ol.2021.12466
- By:
- Publication type:
- Article
OK-432 synergizes with IFN-γ to confer dendritic cells with enhanced antitumor immunity.
- Published in:
- Immunology & Cell Biology, 2014, v. 92, n. 3, p. 263, doi. 10.1038/icb.2013.87
- By:
- Publication type:
- Article